EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advances in Vaccinology and Immunotherapeutics: Vaccine Development, Immune Response Mechanisms, and Strategies for Infectious Disease Prevention

God'sglory Ebubechukwu Ilechukwu, Ehinomhen Inegbedion

Path of Science · 30.09.2026 · 12 (9) · 7015

DOI: 10.22178/pos.134-20 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Path of Science, online erschienen am 30.09.2026. Verfasst von God'sglory Ebubechukwu Ilechukwu und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vaccination remains the primary approach to preventing infectious diseases, but challenges persist: pathogen evolution, waning immunity, incomplete correlates of protection, and disparities in access. This structured narrative review brings together vaccine development, immunological mechanisms, immunotherapeutics and precision vaccinology to show how they work together to prevent disease. We conducted a systematic search of PubMed/MEDLINE, Scopus, WHO IRIS, and PubMed Central, emphasising literature published between 2018 and 2025, and including older foundational literature when relevant. Thematic synthesis was used. This review is neither a systematic review nor a meta-analysis. The themes covered are rational antigen design; live-attenuated, inactivated, protein-subunit, conjugate, viral-vector, mRNA, virus-like-particle, and nanoparticle-based platforms; adjuvants; innate and adaptive immunity; immune memory; efficacy and effectiveness; safety; monoclonal antibodies and other immunotherapeutics; precision vaccinology; mucosal vaccination; pandemic preparedness; and implementation. Structure-guided design and platform technologies have shortened development times and expanded the spectrum of immune responses they can induce. The coordinated innate sensing, antigen presentation, germinal-centre and T-cell responses, and long-term memory are all necessary for protection, but immunogenicity is not a good indicator of protection. Trial efficacy is higher and more durable than real-world effectiveness against evolving pathogens. Immunotherapeutics complement vaccination in infants and immunocompromised individuals, while precision approaches remain largely experimental. Unresolved research gaps include: Durability, correlates of protection, broadly protective antigens, mucosal immunity, validation of systems-based prediction, and equitable manufacturing and access. Modern vaccinology brings together molecular design, immunology, biotechnology, systems approaches, and implementation science; all must be aligned to achieve population impact.

Zitieren

APA

Ilechukwu, G. E., & Inegbedion, E. (2026). Advances in Vaccinology and Immunotherapeutics: Vaccine Development, Immune Response Mechanisms, and Strategies for Infectious Disease Prevention. Path of Science, 12(9), 7015. https://doi.org/10.22178/pos.134-20

Vancouver

Ilechukwu GE, Inegbedion E. Advances in Vaccinology and Immunotherapeutics: Vaccine Development, Immune Response Mechanisms, and Strategies for Infectious Disease Prevention. Path of Science. 2026;12(9):7015. doi:10.22178/pos.134-20

BibTeX
@article{Ilechukwu2026,
  author = {Ilechukwu, God'sglory Ebubechukwu and Inegbedion, Ehinomhen},
  title = {Advances in Vaccinology and Immunotherapeutics: Vaccine Development, Immune Response Mechanisms, and Strategies for Infectious Disease Prevention},
  journal = {Path of Science},
  year = {2026},
  volume = {12},
  number = {9},
  pages = {7015},
  doi = {10.22178/pos.134-20}
}
Kostenlos starten →